Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameNational Science Advisory Board for BiosecurityAgency NameDepartment of Health and Human Services
Fiscal Year2019Committee Number21482
Original Establishment Date11/22/1962Committee StatusChartered
Actual Termination Date Committee URLhttp://osp.od.nih.gov/office-biotechnology-acti...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*44
Current Charter Date4/7/2018Designated Fed Officer Position Title*Director, Division of Biosafety, Biosecurity, and Emerging Biotechnology Policy
Date Of Renewal Charter4/7/2020Designated Federal Officer PrefixDr.
Projected Termination Date Designated Federal Officer First Name*Jessica
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Tucker
Establishment Authority*Authorized by LawDesignated Federal Officer Suffix
Specific Establishment Authority*42 USC 217a, Section 222 of the PHSDesignated Federal Officer Phone*301-451-4431
Effective Date Of Authority*11/22/1962Designated Federal Officer Fax*301-496-9839
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*tuckerjm@mail.nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The purpose of the National Science Advisory Board for Biosecurity (NSABB) is to provide, as requested, advice, guidance and leadership to the Federal Government regarding biosecurity oversight of dual use life sciences research—defined as life sciences research with legitimate scientific purpose that generates information, products, or technologies that may be misused to pose a threat to public health or national security. The NSABB advises the Secretary of the Department of Health and Human Services (HHS), the Director of the National Institutes of Health (NIH), and the heads of all federal departments and agencies that conduct or support life science research. The NSABB meets as needed, typically in public session, to complete tasks assigned by the United States Government. Working Groups of the NSABB convene between full Board meetings to work on assigned issues and to develop draft reports. Working Group progress reports and draft reports are ultimately presented to the full Board for its consideration, input, and approval. Final NSABB recommendations and reports are submitted to the NIH Director, HHS Secretary, and the heads of other Federal agencies that conduct or support life sciences research.
How is membership balanced?*In advising on the efficient and effective oversight of dual use life sciences research, the NSABB must consider both public health and national security needs and the needs of the research community. Because this requires a diverse range of expertise, the Committee is composed of up to 25 voting members who provide broad expertise in areas such as clinical infectious disease, laboratory biosafety/biosecurity, public health and epidemiology, pharmaceutical production, veterinary medicine, plant health, molecular biology and genomics, national security, biodefense, law and law enforcement, ethics, and scientific publishing. In appointing these members, careful consideration is also given to geographic, gender, and race/ethnicity balance. In addition, nonvoting ex officio members represent various federal departments and agencies.
How frequent & relevant are cmte mtgs?*The number of committee meetings varies by year because the NSABB is convened on an as-needed basis rather than on a periodic basis. The NSABB was not convened during this reporting period. The NSABB delivered its report on the 2014 variola virus incident on the NIH Bethesda campus in May 2017 and assisted in planning a September 2017 meeting to solicit feedback from stakeholders about their experiences implementing the U.S. Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC) and the impact of the policy on the research enterprise. The 2016 NSABB report, "Recommendations for the Evaluation and Oversight of Proposed Gain-of-Function Research" informed the development of policy guidance issued by the White House Office of Science and Technology Policy (OSTP) in January 2017. HHS subsequently issued a “Framework for Guiding Funding Decisions about Proposed Research Involving Enhanced Potential Pandemic Pathogens” in December 2017 and has committed to periodically tasking the NSABB to help inform HHS reviews of the implementation of the framework.
Why advice can't be obtained elsewhere?*The NSABB is the only Federal advisory committee chartered to advise the Federal Government on the management and oversight of dual use research; a constantly evolving challenge with significant implications for national biodefense, biosafety and biosecurity, and maintenance of a strong U.S. bioeconomy. The NSABB also brings together a unique and broad range of perspectives and expertise, including biomedical, plant, and animal research; biosecurity, law, law enforcement, scientific publishing, biodefense, and intelligence.
Why close or partially close meetings?N/A
Recommendation RemarksThe projected costs for FY2020 year are increased because NSABB will be holding three 2-day meetings.

Daily salary costs are estimated in the projected costs for Federal and Ex Officio members for FY2020. This dollar figure represents a portion of their annual salary. No funds will be transferred between the committee and the agency. No additional funds will be paid to Federal employees due to their membership on this committee.

Also, no Federal salary costs are being reported this fiscal year because there weren't any NSABB meetings during the fiscal year.

Member, Dr. Stanley, resigned on 8/8/2018 and this information was not captured on the FY18 ACR report. Drs. Morse and Lee were administratively extended until December 14, 2019.

Ex-Officios, Hu-Primmer, Jayan, Shaw, Dion-Schultz and Miceli records were updated to reflect their continuation of service on this committee.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchNoAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherYes
Outcome Increased Customer SatisfactionNoAction CommentThe NSABB makes recommendations to federal departments and agencies on the oversight of life sciences dual use research of concern. For example, NSABB recommendations informed the development and implementation of federal policy to guide federal funding decisions on proposed research that is reasonably anticipated to create, transfer, or use enhanced potential pandemic pathogens.
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherYesNumber Of Grants Reviewed0
Outcome CommentThe Committee is advisory on significant policy issues that have the potential to affect the oversight of all federally-funded life sciences research. In addition, the policies that are informed by its recommendations help ensure that the scientific community conducts and communicates its research in a responsible manner.Number Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentThis Committee provides advice, guidance, and leadership as stated in the narrative above. It can take many years for the impacts of these recommendations to come to fruition.Grants Review CommentN/A
Number Of Recommendations*229Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe committee issued no recommendations in FY19.Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentDue to the large breadth and complexity of the recommendations made by this committee on policy and program areas, NIH staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee’s activities.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentDue to the large breadth and complexity of the recommendations made by this committee on policy and program areas, NIH staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee’s activities.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback CommentMeeting minutes, written reports, and oral presentations.Narrative Description*The purpose of the National Science Advisory Board for Biosecurity (NSABB) is to provide advice, guidance, and leadership regarding biosecurity oversight of dual use research, defined as biological research with legitimate scientific purpose that may be misused to pose a threat to public health and/or national security. The NSABB advises the Secretary of the Department of Health and Human Services (HHS), the Director of the National Institutes of Health (NIH), and the heads of all federal departments and agencies that conduct or support life science research. The NSABB advises on and recommends specific strategies for the efficient and effective oversight of federally conducted or supported dual use biological research, taking into consideration both national security concerns and the needs of the research community.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$0.00Est Payments to Non-Fed Members Next FY*$18,600.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$76,800.00
Payments to Federal Staff*$55,158.00Estimated Payments to Federal Staff*$97,710.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$95,000.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$50,000.00
Other Costs$17,138.00Est. Other Costs Next FY*$306,798.00
Total Costs$72,296.00Est. Total Next FY*$644,908.00
Federal Staff Support (FTE)*0.40Est. Fed Staff Support Next FY*0.80
Hide Section - Custom Links

Custom Links

     Committee Level Reports               
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-034678National Science Advisory Board for Biosecurity2018
 COM-001708National Science Advisory Board for Biosecurity2017
 COM-002297National Science Advisory Board for Biosecurity2016
 COM-004091National Science Advisory Board for Biosecurity2015
 COM-004416National Science Advisory Board for Biosecurity2014
 COM-006234National Science Advisory Board for Biosecurity2013
 COM-006882National Science Advisory Board for Biosecurity2012
 COM-008283National Science Advisory Board for Biosecurity2011
 COM-009061National Science Advisory Board for Biosecurity2010
 COM-010086National Science Advisory Board for Biosecurity2009
 COM-010953National Science Advisory Board for Biosecurity2008
 COM-012229National Science Advisory Board for Biosecurity2007
 COM-012532National Science Advisory Board for Biosecurity2006
 COM-014064National Science Advisory Board for Biosecurity2005
 COM-014595National Science Advisory Board for Biosecurity2004